- Home
- KPTI vs THCH Comparison
KPTI vs THCH Comparison
Compare KPTI & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- THCH
- Stock Information
- Founded
- KPTI 2008
- THCH 2018
- Country
- KPTI United States
- THCH China
- Employees
- KPTI N/A
- THCH N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- THCH Blank Checks
- Sector
- KPTI Health Care
- THCH Finance
- Exchange
- KPTI Nasdaq
- THCH Nasdaq
- Market Cap
- KPTI 102.4M
- THCH 84.2M
- IPO Year
- KPTI 2013
- THCH N/A
- Fundamental
- Price
- KPTI $6.29
- THCH $2.46
- Analyst Decision
- KPTI Strong Buy
- THCH
- Analyst Count
- KPTI 7
- THCH 0
- Target Price
- KPTI $31.71
- THCH N/A
- AVG Volume (30 Days)
- KPTI 302.2K
- THCH 8.5K
- Earning Date
- KPTI 11-11-2025
- THCH 11-11-2025
- Dividend Yield
- KPTI N/A
- THCH N/A
- EPS Growth
- KPTI N/A
- THCH N/A
- EPS
- KPTI N/A
- THCH N/A
- Revenue
- KPTI $137,269,000.00
- THCH $187,316,342.00
- Revenue This Year
- KPTI $3.40
- THCH N/A
- Revenue Next Year
- KPTI $9.69
- THCH N/A
- P/E Ratio
- KPTI N/A
- THCH N/A
- Revenue Growth
- KPTI N/A
- THCH N/A
- 52 Week Low
- KPTI $3.51
- THCH $1.95
- 52 Week High
- KPTI $16.95
- THCH $5.15
- Technical
- Relative Strength Index (RSI)
- KPTI 53.09
- THCH 39.56
- Support Level
- KPTI $5.71
- THCH $2.39
- Resistance Level
- KPTI $6.75
- THCH $2.63
- Average True Range (ATR)
- KPTI 0.58
- THCH 0.10
- MACD
- KPTI 0.03
- THCH -0.01
- Stochastic Oscillator
- KPTI 81.25
- THCH 28.12
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.